ETA receptor-mediated Ca2+ mobilisation in H9c2 cardiac cells

Biochemical Pharmacology

Volumn 65, Issue 5, 2003, Pages 783-793

  Ceccarelli, Francesca ^a   Scavuzzo, Maria C ^a   Giusti, Laura ^a   Bigini, Gianni ^a   Costa, Barbara ^a   Carnicelli, Vittoria ^a   Zucchi, Riccardo ^a   Lucacchini, Antonio ^a   Mazzoni, Maria R ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Ca2+ channels; Endothelin receptors; H9c2 cells; IP3 receptors; Ryanodine receptors

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM ION; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DANTROLENE; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR AGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; FLUCONAZOLE; INOSITOL 1,4,5 TRISPHOSPHATE; IODINE 125; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N ACETYL 10,11 DIHYDRO 5H DIBENZO[A,D]CYCLOHEPTEN 5 YLGLYCYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN; NIFEDIPINE; PROTEIN KINASE C; RYANODINE RECEPTOR; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE]; CALCIUM; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; RADIOACTIVE IODINE;

ANIMAL CELL; ARTICLE; BINDING SITE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; FLOW CYTOMETRY; FLUORESCENCE; HEART MUSCLE CELL; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; BIOSYNTHESIS; CALCIUM SIGNALING; CELL CULTURE; HEART MUSCLE; METABOLISM; PHYSIOLOGY;

ANIMALS; BINDING SITES; CALCIUM; CALCIUM SIGNALING; CELLS, CULTURED; ENDOTHELIN-1; IMMUNOBLOTTING; IODINE RADIOISOTOPES; MYOCARDIUM; RATS; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 0037334293     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01624-6     Document Type: Article

References (43)

1. Yanagisawa M., Kurihara H., Kimura S., Tombe T., Kobajashi M., Mitsui Y., Yazaki Y., Goto J., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
2. Inoue A., Yanagiswa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by separate genes. Proc. Natl. Acad. Sci. U.S.A. 86:1989;2863-2867.
3. Pollock D.M., Keith T.L., Highsmith R.F. Endothelin receptor and calcium signaling. FASEB J. 9:1995;1196-1204.
4. Gray G.A., Battistini B., Webb D.J. Endothelins are potent vasoconstrictors and much more besides. Trends Pharmacol. Sci. 21:2000;38-40.
5. Sokolovsky M. Endothelin receptor subtypes and their role in transmembrane signaling mechanisms. Pharmacol. Ther. 68:1995;435-471.
6. Rubanyi G.M., Polokoff M.A. Endothelins: molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol. Rev. 46:1994;325-415.
7. Webb M.L., Meek T.D. Inhibitors of endothelin. Med. Res. Rev. 17:1997;17-67.
8. 2+-permeable nonselective cation channel in rat aortic smooth muscle cells. Br. J. Pharmacol. 120:1997;1536-1544.
9. Russell F.D., Molenaar P. The human heart endothelin system: ET-1 synthesis, storage, release and effects. Trends Pharmacol. Sci. 21:2000;353-359.
10. Molenaar P., O'Reilly G., Sharkey A., Kuc R.E., Harding D.P., Plumpton C., Gresham G.A., Davenport A.P. Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ. Res. 72:1993;526-538.
11. Serneri G.G., Cecioni I., Vanni S., Paniccia R., Bandinelli B., Vetere A., Janming X., Bertolozzi I., Boddi M., Lisi G.F., Sani G., Modesti P.A. Selective upregulation of cardiac endothelin system in patients with ischemic but not idiopathic dilated cardiomyopathy: endothelin-1 system in the human failing heart. Circ. Res. 86:2000;377-385.
12. Hilal-Dandan R., Merck D.T., Lujan J.P., Brunton L.L. Coupling of the type A endothelin receptor to multiple responses in adult rat cardiac myocytes. Mol. Pharmacol. 45:1994;1183-1190.
13. A receptor regulates signaling and ANF gene expression via multiple G protein-linked pathways. Am. J. Physiol. 272:1997;H130-H137.
14. Hescheler J., Meyer R., Plant S., Krautwurst D., Rosenthal W., Schultz G. Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ. Res. 169:1991;1476-1486.
15. Menard C., Pupier S., Mornet D., Kitzmann M., Nargeot J., Lory P. Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells. J. Biol. Chem. 274:1999;29063-29070.
16. Szalai G., Csordas G., Hantash B.M., Thomas A.P., Hajnoczky G. Calcium signal transmission between ryanodine receptors and mitochondria. J. Biol. Chem. 275:2000;15305-15313.
17. Tran K., Zha X., Chan M., Choy P.C. Enhancement of phospholipid hydrolysis in vasopressin-stimulated BHK-21 and H9c2 cells. Mol. Cell. Biochem. 151:1995;69-76.
18. 2+ stores. J. Biol. Chem. 273:1998;3747-3755.
19. 2+ and the protein kinase C-dependent activation of p42 mitogen-activated protein kinase. Endocrinology. 140:1999;1639-1648.
20. Brostrom M.A., Reilly B.A., Wilson F.J., Brostrom C.O. Vasopressin-induced hypertrophy in H9c2 heart derived myocites. Int. J. Biochem. Cell Biol. 32:2000;993-1006.
21. 2+ uptake. Circulation. 102:2000;1582-1588.
22. Giannessi D., Del Ry S., Vitale R.L. The role of endothelins and their receptors in heart failure. Pharmacol. Res. 43:2001;111-126.
23. Lowry O.H., Rosebrough N.J., Farr A., Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
24. B receptors in guinea-pig bronchus. Br. J. Pharmacol. 127:1999;1406-1414.
25. 2+ handling and contractile function in rat heart. Br. J. Pharmacol. 131:2000;342-348.
26. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
27. Vandenberghe P.A., Ceuppens J.L. Flow cytometric measurement of cytoplasmic free calcium in human peripheral blood T lymphocytes with fluo-3, a new fluorescent calcium indicator. J. Immunol. Methods. 127:1990;197-205.
28. Koopman G., Reutelingsperger C.P., Kuijten G.A., Keehnen R.M., Pals S.T., Van Oers M.H. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 84:1994;1415-1420.
29. McPherson G.A. Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. J. Pharmacol. Methods. 14:1985;213-228.
30. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
31. Kochl R., Alken M., Rutz C., Krause G., Oksche A., Rosenthal W., Schulein R. The signal peptide of the G protein-coupled human endothelin B receptor is necessary for translocation of the N-terminal tail across the endoplasmic reticulum membrane. J. Biol. Chem. 277:2002;16131-16138.
32. Bleasdale J.E., Thakur N.R., Gremban R.S., Bundy G.L., Fitzpatrick F.A., Smith R.J., Bunting S. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J. Pharmacol. Exp. Ther. 255:1990;756-768.
33. 2+ oscillations in response to cholecystokinin and carbachol but not to JMV-180 in rat pancreatic acinar cells. J. Biol. Chem. 267:1992;13830-13835.
34. 2+ release in rat portal vein myocytes. Mol. Pharmacol. 55:1999;684-692.
35. Smith R.J., Sam L.M., Justen J.M., Bundy G.L., Bala G.A., Bleasdale J.E. Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness. J. Pharmacol. Exp. Ther. 253:1990;688-697.
36. 2+ signaling requirements. Biochem. J. 337:1999;153-169.
37. 2+ current by activation of protein kinase C in rat ventricular myocytes. J. Physiol. 524:2000;807-820.
38. Herbert J.M., Augereau J.M., Gleye J., Maffrand J.P. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172:1990;993-999.
39. Ward N.E., O'Brian C.A. Inhibition of protein kinase C by N-myristoylated peptide substrate analogs. Biochemistry. 32:1993;11903-11909.
40. Gupta K.P., Ward N.E., Gravitt K.R., Bergman P.J., O'Brian C.A. Partial reversal of multidrug resistance in human breast cancer cells by an N-myristoylated protein kinase C-α pseudosubstrate peptide. J. Biol. Chem. 271:1996;2102-2111.
41. B receptors by cations and GTPγS. Biochem. Pharmacol. 62:2001;537-545.
42. V1.2a,b) by protein kinases. Am. J. Physiol. Cell Physiol. 281:2001;C1743-C1756.
43. Wojcikiewicz R.J., Luo S.G. Phosphorylation of inositol 1,4,5-trisphosphate receptors by cAMP-dependent protein kinase. Type I, II, and III receptors are differentially susceptible to phosphorylation and are phosphorylated in intact cells. J. Biol. Chem. 273:1998;5670-5677.